Diagnosis of EVALI: General Approach and the Role of Bronchoscopy

Chest. 2020 Aug;158(2):820-827. doi: 10.1016/j.chest.2020.02.018. Epub 2020 Feb 21.

Abstract

A 23-year-old man arrives at the ED with a 3-week history of dyspnea, dry cough, fevers, and night sweats. Two weeks previously, he was evaluated in an outpatient clinic and given a course of azithromycin for presumed infectious pneumonia. His symptoms did not improve, and he was seen 1 week later in an urgent care center and given a prescription for doxycycline, which he has been taking without improvement. He states that he feels miserable, has severe nausea and vomiting, and has not eaten in several days. His only medical history is childhood asthma. He reports no surgeries and takes no medications. He has no risk factors for HIV, does not smoke combustible cigarettes or use IV drugs, and has not recently traveled. Examination shows a room air saturation of 89%, a temperature of 38.3°C, and a respiratory rate of 22 breaths/min. Results of his examination are normal, and there are no rales or wheezing heard in the lungs. Chest radiograph shows bilateral, consolidative opacities. WBC count is 14,000, with left shift. Results of biochemistries are normal. Erythrocyte sedimentation rate is 104, and procalcitonin is 0.08. Urine toxicology screen is positive for tetrahydrocannabinol (THC). Asked specifically about vaping and e-cigarette use, he reports that he recently began using THC "carts" that his friend gets from an unknown supplier. What is the diagnosis and what additional steps are necessary to confirm it? Is bronchoscopy indicated?

Keywords: EVALI; bronchoscopy; e-cigarettes; vaping.

Publication types

  • Review

MeSH terms

  • Bronchoscopy*
  • Diagnosis, Differential
  • Humans
  • Lung Injury / chemically induced*
  • Lung Injury / diagnosis*
  • Radiography, Thoracic
  • Vaping / adverse effects*